Amicus Therapeutics Inc Capital Reinvestment Ratio
Amicus Therapeutics Inc capital reinvestment ratio. Amicus Therapeutics Inc (FOLD) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow ($16.25 Million) in capital expenditures ($299.00K). Check total reinvestment intensity of Amicus Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Amicus Therapeutics Inc (2007–2025)
Capital reinvestment ratio of Amicus Therapeutics Inc from 2007 to 2025. This chart tracks Amicus Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. Also explore Amicus Therapeutics Inc equity growth rate to track the company's year-over-year net asset growth rate.
Amicus Therapeutics Inc Capital Reinvestment Ratio by Year (2007–2025)
Amicus Therapeutics Inc capital reinvestment ratio by year from 2007 to 2025. For the full cash flow conversion analysis, see Amicus Therapeutics Inc cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | $33.15 Million | $3.30 Million | ▲ +125.8% |
| 2007 | 0.04x | $15.19 Million | $669.00K | — |